Tag Archives: BIO CEO & Investor Conference

Vote for the Buzz of BIO at the 2016 BIO CEO & Investor Conference

Buzz of BIO

Voting is now open! See the 20 nominees and cast your vote once per day in the Buzz of BIO contest. Don’t forget to register for the BIO CEO & Investor Conference; early bird discounts end December 17. Ten biotechs were nominated in two categories, “Most Buzzworthy Public Company” and “Most Buzzworthy Private Company.” To qualify for the Most Buzzworthy Public Company Grand Prize, companies must be publicly traded and headquartered in the United States. To qualify for Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Be the Buzz of BIO at the 2016 BIO CEO and Investor Conference

Buzz of BIO contest, BIO Investor Forum

The nomination period is underway for the Buzz of BIO content at the 2016 CEO & Investor Conference! Each winner will receive a complimentary registration and presentation in the corresponding presentation track, and have the opportunity to impress investors with their company’s latest developments. The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

The Perfect Close

72263479

With a fast and furious finish, yesterday, March 2nd, the Nasdaq Composite (IXIC) closed at 5,008.10, marking the third day in history with a close above 5,000. Since 95% of US publicly traded biotech companies are listed on the Nasdaq exchange, the team at BIO couldn’t help but join the excitement. Back in 2000, the Nasdaq index was flourishing with dot coms. At that point there was no Facebook or Netflix and Google wasn’t public. Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers

bio-ceo-blog

The 17th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place last week in New York City at the Waldorf Astoria with more than 1,400 registrants, including 620 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 5 fireside chats with biotech and pharma CEOs as well as nearly 170 company presentations. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

FOX Business: BIO CEO Jim Greenwood Discusses Future of Medicine

IMG_0012

BIO President and CEO Jim Greenwood appeared on Fox Business during the 17th Annual BIO CEO & Investor Conference in New York City to discuss the future of medicine. Against a backdrop of policy discussions focused on how to encourage and incentivize innovation, this week’s conference hosted a record number of partnering meetings, as Greenwood emphasizes in the interview. Greenwood goes on to point out that investors closely follow policy trends, and their interest in Read More >

Events, Health  |  1 Comment  |  Email This Post
Tags: , , , , ,